Investors Pile Into Amgen in Search of Next Obesity Drug Payout [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
(Bloomberg) -- Investors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc. Most Read from Bloomberg Truce Talks Drag as Hamas Hits Israel Crossing in Deadly Attack Buffett Praises Apple After Trimming It, Drops Paramount Stake France's Macron Calls for Reset of Economic Ties With China Treasury Rally Risks Running Into a $125 Billion Brick Wall Xi Begins Europe Tour in Paris as Macron Seeks to Reset Ties The shares surged 12% Friday, the biggest one-day jump for Amgen in nearly 15 years, fueled by fresh optimism about the company's future in the lucrative market for weight-loss drugs after upbeat commentary from the chief executive officer. Although it could take years for a drug to come to market, investors who are looking for new ways trade into the hype are betting that the Amgen's anti-obesity entrant, MariTide, could compete against current blockbusters. Wall Street's enthusiasm
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds [Yahoo! Finance]Yahoo! Finance
- Mounjaro And Zepbound Shortages Targeted With $5.3 Billion Eli Lilly Investment [Forbes]Forbes
- Eli Lilly's big GLP-1 investment — plus, what we want from 4 portfolio stock earnings [MSNBC.com]MSNBC.com
- Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro [Yahoo! Finance]Yahoo! Finance
- 3 Healthcare Mutual Funds You Should Consider Buying [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 5/24/24 - Form 4
- 5/24/24 - Form 144
- 5/23/24 - Form 4
- LLY's page on the SEC website